Rowland & CO Investment Counsel Pfizer Inc Transaction History

Rowland & CO Investment Counsel

$486 Million
Q3 2024

A detailed history of Rowland & CO Investment Counsel transactions in Pfizer Inc stock. As of the latest transaction made, Rowland & CO Investment Counsel holds 84,109 shares of PFE stock, worth $2.18 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

84,109

Previous 83,207 1.08%

Holding current value

$2.18 Million

Previous $2.33 Million 4.55%

% of portfolio

0.5%

Previous 0.51%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$27.7 - $31.39 $24,985 - $28,313	902 Added 1.08%	84,109 $2.43 Million
Q2 2024 Jul 29, 2024	BUY	$25.26 - $29.6 $109,603 - $128,434	4,339 Added 5.5%	83,207 $2.33 Million
Q1 2024 Apr 08, 2024	BUY	$25.89 - $29.73 $251,184 - $288,440	9,702 Added 14.03%	78,868 $2.19 Million
Q4 2023 Jan 03, 2024	SELL	$26.13 - $33.94 $46,380 - $60,243	-1,775 Reduced 2.5%	69,166 $1.99 Million
Q3 2023 Oct 26, 2023	SELL	$32.09 - $37.51 $40,722 - $47,600	-1,269 Reduced 1.76%	70,941 $2.35 Million
Q2 2023 Aug 04, 2023	SELL	$36.12 - $41.79 $61,584 - $71,251	-1,705 Reduced 2.31%	72,210 $2.65 Million
Q1 2023 Apr 25, 2023	BUY	$39.39 - $51.28 $12,722 - $16,563	323 Added 0.44%	73,915 $3.02 Million
Q4 2022 Jan 04, 2023	SELL	$41.75 - $54.5 $15,364 - $20,056	-368 Reduced 0.5%	73,592 $0
Q3 2022 Oct 06, 2022	BUY	$43.76 - $53.42 $2,931 - $3,579	67 Added 0.09%	73,960 $3.24 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $1,582 - $1,875	34 Added 0.05%	73,893 $3.87 Million
Q1 2022 Apr 26, 2022	SELL	$45.75 - $56.69 $19,992 - $24,773	-437 Reduced 0.59%	73,859 $3.82 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $519,433 - $769,973	12,571 Added 20.37%	74,296 $4.39 Million
Q3 2021 Nov 08, 2021	SELL	$39.25 - $50.42 $435,243 - $559,107	-11,089 Reduced 15.23%	61,725 $2.65 Million
Q2 2021 Aug 09, 2021	BUY	$35.91 - $40.68 $184,900 - $209,461	5,149 Added 7.61%	72,814 $2.85 Million
Q1 2021 May 11, 2021	BUY	$33.49 - $37.77 $109,545 - $123,545	3,271 Added 5.08%	67,665 $2.45 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $97,230 - $123,636	2,905 Added 4.72%	64,394 $2.37 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $7,493 - $8,791	-236 Reduced 0.38%	61,489 $2.14 Million
Q2 2020 Aug 10, 2020	BUY	$30.12 - $36.54 $7,108 - $8,623	236 Added 0.38%	61,725 $1.91 Million
Q1 2020 May 11, 2020	SELL	$27.03 - $38.62 $10,109 - $14,443	-374 Reduced 0.6%	61,489 $1.9 Million
Q4 2019 Jan 28, 2020	BUY	$32.92 - $37.36 $15,143 - $17,185	460 Added 0.75%	61,863 $2.3 Million
Q3 2019 Oct 02, 2019	BUY	$32.49 - $42.13 $47,922 - $62,141	1,475 Added 2.46%	61,403 $2.09 Million
Q2 2019 Jul 09, 2019	BUY	$36.98 - $41.52 $4,622 - $5,190	125 Added 0.21%	59,928 $0
Q1 2019 Apr 10, 2019	SELL	$37.5 - $41.2 $38,100 - $41,859	-1,016 Reduced 1.67%	59,803 $0
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $78,247 - $89,211	2,034 Added 3.46%	60,819 $2.52 Million
Q3 2018 Oct 22, 2018	SELL	$34.47 - $41.81 $64,389 - $78,101	-1,868 Reduced 3.08%	58,785 $0
Q2 2018 Jul 11, 2018	BUY	$32.98 - $35.16 $164 - $175	5 Added 0.01%	60,653 $0
Q1 2018 Apr 17, 2018	BUY	$31.91 - $37.02 $20,454 - $23,729	641 Added 1.07%	60,648 $0
Q4 2017 Jan 11, 2018	SELL	$33.26 - $35.29 $26,474 - $28,090	-796 Reduced 1.31%	60,007 $0
Q3 2017 Oct 11, 2017	SELL	$31.0 - $34.15 $54,746 - $60,308	-1,766 Reduced 2.82%	60,803 $0
Q3 2017 Oct 11, 2017	BUY	$31.0 - $34.15 $1.94 Million - $2.14 Million	62,569	62,569 $0

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rowland & CO Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Rowland & CO Investment Counsel with notifications on news.

Account

Rowland & CO Investment Counsel Pfizer Inc Transaction History